loading
Precedente Chiudi:
$38.09
Aprire:
$38
Volume 24 ore:
1.06M
Relative Volume:
1.68
Capitalizzazione di mercato:
$2.88B
Reddito:
$13.17M
Utile/perdita netta:
$-199.06M
Rapporto P/E:
-13.97
EPS:
-2.74
Flusso di cassa netto:
$-156.53M
1 W Prestazione:
+1.75%
1M Prestazione:
+21.68%
6M Prestazione:
-8.18%
1 anno Prestazione:
-10.98%
Intervallo 1D:
Value
$37.74
$38.96
Intervallo di 1 settimana:
Value
$36.94
$39.01
Portata 52W:
Value
$26.74
$46.00

Xenon Pharmaceuticals Inc Stock (XENE) Company Profile

Name
Nome
Xenon Pharmaceuticals Inc
Name
Telefono
(604) 484-3300
Name
Indirizzo
200 - 3650 GILMORE WAY, BURNABY
Name
Dipendente
327
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
XENE's Discussions on Twitter

Confronta XENE con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
XENE
Xenon Pharmaceuticals Inc
38.28 2.88B 13.17M -199.06M -156.53M -2.74
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
501.15 126.96B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
605.61 65.06B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
649.67 37.54B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
259.39 32.56B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
255.77 26.40B 3.81B -644.79M -669.77M -6.24

Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-11 Iniziato Deutsche Bank Buy
2024-10-10 Ripresa Raymond James Outperform
2024-10-01 Iniziato H.C. Wainwright Buy
2024-01-04 Iniziato Citigroup Buy
2023-12-08 Iniziato Robert W. Baird Outperform
2023-10-24 Ripresa Cantor Fitzgerald Overweight
2023-04-25 Iniziato Cantor Fitzgerald Overweight
2022-12-14 Iniziato Goldman Buy
2022-12-12 Iniziato Cowen Outperform
2022-11-28 Iniziato Wells Fargo Overweight
2022-10-19 Iniziato Raymond James Outperform
2022-08-29 Iniziato BofA Securities Buy
2022-07-21 Iniziato JP Morgan Overweight
2021-10-28 Iniziato RBC Capital Mkts Outperform
2020-10-02 Iniziato SVB Leerink Outperform
2020-07-21 Iniziato Needham Buy
2020-06-01 Ripresa Jefferies Buy
2020-03-25 Iniziato Wedbush Outperform
2020-01-08 Iniziato William Blair Outperform
2019-09-20 Iniziato Guggenheim Buy
2018-08-08 Reiterato Stifel Buy
2017-03-13 Iniziato Jefferies Buy
2016-10-21 Iniziato Stifel Buy
2016-09-26 Iniziato Guggenheim Buy
2016-04-14 Reiterato Jefferies Buy
2015-10-30 Ripresa Jefferies Buy
2014-12-02 Iniziato Canaccord Genuity Buy
Mostra tutto

Xenon Pharmaceuticals Inc Borsa (XENE) Ultime notizie

pulisher
03:36 AM

Renaissance Technologies LLC Decreases Stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

03:36 AM
pulisher
01:20 AM

Xenon Pharmaceuticals (NASDAQ:XENE) Stock Rating Lowered by StockNews.com - Defense World

01:20 AM
pulisher
May 02, 2025

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | XENE Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Xenon Pharmaceuticals Announces Equity Inducement Grants to New Employees - TipRanks

May 02, 2025
pulisher
May 02, 2025

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 02, 2025
pulisher
May 02, 2025

Xenon Pharmaceuticals Expands Team with $3M Equity Package: 78,600 Options Granted to New Hires - Stock Titan

May 02, 2025
pulisher
May 02, 2025

This trade activity should not be overlooked: Xenon Pharmaceuticals Inc (XENE) - Sete News

May 02, 2025
pulisher
May 01, 2025

Upward Trajectory: Xenon Pharmaceuticals Inc (XENE) Posts a Slidee, Closing at 38.20 - DWinneX

May 01, 2025
pulisher
May 01, 2025

Xenon Pharmaceuticals Target of Unusually Large Options Trading (NASDAQ:XENE) - Defense World

May 01, 2025
pulisher
Apr 30, 2025

Xenon Pharmaceuticals Inc [XENE] MORTIMER IAN sells 22,468 Shares for $0.9 million - knoxdaily.com

Apr 30, 2025
pulisher
Apr 29, 2025

Geode Capital Management LLC Purchases 720 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Apr 29, 2025
pulisher
Apr 28, 2025

Envestnet Asset Management Inc. Sells 1,539 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Apr 28, 2025
pulisher
Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 26, 2025

Xenon Pharmaceuticals Inc (NASDAQ:XENE)’s 12-Month Price Target Currently Stands At 42 - Marketing Sentinel

Apr 26, 2025
pulisher
Apr 26, 2025

StockNews.com Upgrades Xenon Pharmaceuticals (NASDAQ:XENE) to Hold - Defense World

Apr 26, 2025
pulisher
Apr 26, 2025

Wells Fargo & Company MN Reduces Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Apr 26, 2025
pulisher
Apr 26, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Receives Average Recommendation of “Buy” from Analysts - Defense World

Apr 26, 2025
pulisher
Apr 24, 2025

Market Insights: Xenon Pharmaceuticals Inc (XENE)’s Notable Gain of 2.34, Closing at 37.59 - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

Xenon Pharmaceuticals Inc (XENE) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Xenon Pharmaceuticals (NASDAQ:XENE) Upgraded by StockNews.com to Hold Rating - Defense World

Apr 24, 2025
pulisher
Apr 19, 2025

When (XENE) Moves Investors should Listen - news.stocktradersdaily.com

Apr 19, 2025
pulisher
Apr 19, 2025

The Goldman Sachs Group Has Lowered Expectations for Xenon Pharmaceuticals (NASDAQ:XENE) Stock Price - Defense World

Apr 19, 2025
pulisher
Apr 18, 2025

Xenon- A Later Stage Story (NASDAQ:XENE) - Seeking Alpha

Apr 18, 2025
pulisher
Apr 18, 2025

Xenon Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:XENE) - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Q1 EPS Forecast for Xenon Pharmaceuticals Raised by Analyst - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

Xenon Pharmaceuticals: Undervalued Stock with Promising Catalysts and Growth Potential - TipRanks

Apr 16, 2025
pulisher
Apr 16, 2025

StockNews.com Downgrades Xenon Pharmaceuticals (NASDAQ:XENE) to Sell - Defense World

Apr 16, 2025
pulisher
Apr 07, 2025

XENE stock touches 52-week low at $28.51 amid market shifts By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 07, 2025

XENE stock touches 52-week low at $28.51 amid market shifts - Investing.com

Apr 07, 2025
pulisher
Apr 06, 2025

JPMorgan Chase & Co. Increases Stock Holdings in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Apr 06, 2025
pulisher
Apr 06, 2025

Prudential Financial Inc. Acquires 24,956 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Apr 06, 2025
pulisher
Apr 06, 2025

Raymond James Financial Inc. Buys New Position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Apr 06, 2025
pulisher
Apr 04, 2025

Xenon Pharmaceuticals Looks Attractive Before Epilepsy Data (NASDAQ:XENE) - Seeking Alpha

Apr 04, 2025
pulisher
Apr 04, 2025

Xenon Pharmaceuticals to Present Promising Azetukalner Data at AAN 2025 - TipRanks

Apr 04, 2025
pulisher
Apr 04, 2025

Xenon Slides Ahead of San Diego Concference - Baystreet.ca

Apr 04, 2025
pulisher
Apr 04, 2025

Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025 - The Manila Times

Apr 04, 2025
pulisher
Apr 04, 2025

Breakthrough Epilepsy Drug Shows Remarkable 3-Year Efficacy Data - Stock Titan

Apr 04, 2025
pulisher
Apr 03, 2025

Investors Purchase Large Volume of Put Options on Xenon Pharmaceuticals (NASDAQ:XENE) - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

Xenon Pharmaceuticals Enters Oversold Territory (XENE) - Nasdaq

Apr 01, 2025
pulisher
Apr 01, 2025

Thrivent Financial for Lutherans Sells 12,394 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Apr 01, 2025
pulisher
Apr 01, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Given Consensus Recommendation of “Buy” by Analysts - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Teacher Retirement System of Texas Acquires 2,994 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

11 Best Gene Therapy Stocks to Buy According to Analysts - Insider Monkey

Mar 30, 2025
pulisher
Mar 25, 2025

Focal Epilepsy Market: Analysis of Epidemiology, Pipeline - openPR.com

Mar 25, 2025
pulisher
Mar 25, 2025

Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Shares Bought by Swiss National Bank - Defense World

Mar 25, 2025
pulisher
Mar 24, 2025

(XENE) Trading Advice - news.stocktradersdaily.com

Mar 24, 2025
pulisher
Mar 23, 2025

Xenon Pharmaceuticals announces executive changes - MSN

Mar 23, 2025
pulisher
Mar 23, 2025

Bank of New York Mellon Corp Sells 2,294 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) - Defense World

Mar 23, 2025
pulisher
Mar 20, 2025

What is William Blair’s Estimate for XENE Q1 Earnings? - Defense World

Mar 20, 2025
pulisher
Mar 19, 2025

Xenon Pharmaceuticals at Stifel Forum: Strategic Advances in CNS By Investing.com - Investing.com Canada

Mar 19, 2025
pulisher
Mar 16, 2025

Xenon Pharmaceuticals’ CCO Departure and Consultancy Role - MSN

Mar 16, 2025

Xenon Pharmaceuticals Inc Azioni (XENE) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Xenon Pharmaceuticals Inc Azioni (XENE) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
MORTIMER IAN
PRESIDENT & CEO
Jan 27 '25
Option Exercise
17.76
16,315
289,754
46,468
MORTIMER IAN
PRESIDENT & CEO
Jan 23 '25
Option Exercise
17.76
16,217
288,014
47,519
MORTIMER IAN
PRESIDENT & CEO
Jan 24 '25
Sale
40.20
22,468
903,214
31,302
MORTIMER IAN
PRESIDENT & CEO
Jan 27 '25
Sale
40.50
16,315
660,806
31,302
MORTIMER IAN
PRESIDENT & CEO
Jan 23 '25
Sale
40.08
16,217
649,977
31,302
$72.30
price down icon 0.47%
$21.48
price up icon 2.63%
$32.89
price up icon 1.26%
$27.90
price up icon 13.09%
$104.94
price up icon 2.45%
biotechnology ONC
$255.77
price up icon 0.05%
Capitalizzazione:     |  Volume (24 ore):